Related News
Most of dangerous rabies vaccine recovered in NE China
Source: Xinhua |
February 8, 2009, Sunday
|
Online Edition
Online Edition
A PHARMACEUTICAL company in northeast China has recovered most of the dangerous rabies vaccine that was tested to contain an illegal ingredient, the company spokeswoman said today.
The vaccine, which was produced last year by Dalian Jingang-Andi Bio-products Co. in Dalian City, Liaoning Province, failed the test launched in January by the National Institute for the Control of Pharmaceutical and Biological Products.
The General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ) announced a recall for the vaccine on Friday.
The company produced 360,200 doses of the vaccine last year, and 321,800 of them have been recovered, said Wang Zeqing, the company spokeswoman.
There has been no report of vaccine-related illness so far, she added.
The company has suspended operation since Jan. 14. Only employees engaged in the recall are at work.
Wang promised thorough cooperation with the ongoing investigation.
The nucleic acid ingredient acts as an adjuvant, a substance used to enhance the effectiveness of a drug or a pesticide.
The AQSIQ said earlier that the nucleic acid materials could not be used in human vaccine, since "the experiment had not entered human clinical trials yet."
The company's rabies vaccine accounts for approximately 20 percent of the domestic market, according to the company's website.
In the far western region of Xinjiang, two people died last month after using a fake diabetes drug, which also contained an illegal ingredient. The drug also sent 11 others to hospital in the region.
The vaccine, which was produced last year by Dalian Jingang-Andi Bio-products Co. in Dalian City, Liaoning Province, failed the test launched in January by the National Institute for the Control of Pharmaceutical and Biological Products.
The General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ) announced a recall for the vaccine on Friday.
The company produced 360,200 doses of the vaccine last year, and 321,800 of them have been recovered, said Wang Zeqing, the company spokeswoman.
There has been no report of vaccine-related illness so far, she added.
The company has suspended operation since Jan. 14. Only employees engaged in the recall are at work.
Wang promised thorough cooperation with the ongoing investigation.
The nucleic acid ingredient acts as an adjuvant, a substance used to enhance the effectiveness of a drug or a pesticide.
The AQSIQ said earlier that the nucleic acid materials could not be used in human vaccine, since "the experiment had not entered human clinical trials yet."
The company's rabies vaccine accounts for approximately 20 percent of the domestic market, according to the company's website.
In the far western region of Xinjiang, two people died last month after using a fake diabetes drug, which also contained an illegal ingredient. The drug also sent 11 others to hospital in the region.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
